Ana Gil-Brusola

Ana Gil-Brusola

Auto-generated profile, based on publicly available information

Ana Gil-Brusola

Microbiology Service, Hospital Universitari i Politècnic La Fe, Valencia, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DSDavid Stucki
David Stucki
DBDaniela Brites
Daniela Brites
LJLeïla Jeljeli
Leïla Jeljeli
MCMireia Coscollá
Mireia Coscollá
QLQingyun Liu
Qingyun Liu
SGSebastien Gagneux
Sebastien Gagneux
Sebastien Gagneux and colleagues analyze a global collection of Mycobacterium tuberculosis clinical isolates to classify sublineages by phylogeography. They find globally distributed ‘generalist’ and geographically restricted ‘specialist’ sublineages of lineage 4, indicating that different evolutionary strategies were adopted to succeed in various ecological niches. Generalist and specialist species differ in the breadth of their ecological niches. Little is known about the niche width of obligate human pathogens. Here we analyzed a global collection of Mycobacterium tuberculosis lineage 4 clinical isolates, the most geographically widespread cause of human tuberculosis. We show that lineage 4 comprises globally distributed and geographically restricted sublineages, suggesting a distinction between generalists and specialists. Population genomic analyses showed that, whereas the majority of human T cell epitopes were conserved in all sublineages, the proportion of variable epitopes was higher in generalists. Our data further support a European origin for the most common generalist sublineage. Hence, the global success of lineage 4 reflects distinct strategies adopted by different sublineages and the influence of human migration.

31 October 2019 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
YXYuanwei Xu
Yuanwei Xu
ICIrving Cancino-Muñoz
Irving Cancino-Muñoz
MTManuela Torres-Puente
Manuela Torres-Puente
LVLuis M Villamayor
Luis M Villamayor
RBRafael Borrás
Rafael Borrás
ICIñaki Comas
Iñaki Comas
Whole genome sequencing provides better delineation of transmission clusters in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal individual transmission links within clusters is limited. Here, we used a 2-step approach based on Bayesian transmission reconstruction to (1) identify likely index and missing cases, (2) determine risk factors associated with transmitters, and (3) estimate when transmission happened. We developed our transmission reconstruction method using genomic and epidemiological data from a population-based study from Valencia Region, Spain. Tuberculosis (TB) incidence during the study period was 8.4 cases per 100,000 people. While the study is ongoing, the sampling frame for this work includes notified TB cases between 1 January 2014 and 31 December 2016. We identified a total of 21 transmission clusters that fulfilled the criteria for analysis. These contained a total of 117 individuals diagnosed with active TB (109 with epidemiological data). Demographic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-born, 76/109 (70%) individuals were men, and the mean age was 42.51 years (SD 18.46). We found that 66/109 (61%) TB patients were sputum positive at diagnosis, and 10/109 (9%) were HIV positive. We used the data to reveal individual transmission links, and to identify index cases, missing cases, likely transmitters, and associated transmission risk factors. Our Bayesian inference approach suggests that at least 60% of index cases are likely misidentified by local public health. Our data also suggest that factors associated with likely transmitters are different to those of simply being in a transmission cluster, highlighting the importance of differentiating between these 2 phenomena. Our data suggest that type 2 diabetes mellitus is a risk factor associated with being a transmitter (odds ratio 0.19 [95% CI 0.02–1.10], p < 0.003). Finally, we used the most likely timing for transmission events to study when TB transmission occurred; we identified that 5/14 (35.7%) cases likely transmitted TB well before symptom onset, and these were largely sputum negative at diagnosis. Limited within-cluster diversity does not allow us to extrapolate our findings to the whole TB population in Valencia Region. In this study, we found that index cases are often misidentified, with downstream consequences for epidemiological investigations because likely transmitters can be missed. Our findings regarding inferred transmission timing suggest that TB transmission can occur before patient symptom onset, suggesting also that TB transmits during sub-clinical disease. This result has direct implications for diagnosing TB and reducing transmission. Overall, we show that a transition to individual-based genomic epidemiology will likely close some of the knowledge gaps in TB transmission and may redirect efforts towards cost-effective contact investigations for improved TB control.

1 December 2011 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
CBC. Barona-Vilar
C. Barona-Vilar
MGM. J. Giménez-Martí
M. J. Giménez-Martí
TFT. Fraile
T. Fraile
CGC. González-Steinbauer
C. González-Steinbauer
CPC. Parada
C. Parada
RBR. Borrás
R. Borrás
SUMMARY: This study describes the results of the health programme implemented in the Valencian Community (Spain) to achieve an early diagnosis of Chagas disease in pregnant Latin American women and their newborns. During 2009 and 2010, 1975 women living in the health districts of three university hospitals were enrolled via midwives or at the time of delivery. Diagnosis of disease was performed using two serological tests with different antigens. Congenital infection was diagnosed by parasitological, molecular or serological methods from blood samples obtained at birth or in subsequent controls. The overall seroprevalence of Chagas infection in pregnant women from 16 different endemic countries was 11·4%. Infection was higher in those from countries in the Gran Chaco Region (Bolivia, 34·1%; Paraguay, 7·4%; Argentina, 5·3%). Eight newborn infants from Bolivian mothers had congenital Chagas which represents a vertical transmission rate of 3·7%. In conclusion, this work supports the benefits of offering an early diagnosis to pregnant women and newborns during routine prenatal healthcare.

1 July 2011 in Transplantation Proceedings
Verified
Journal Article
Closed access
MSM. Santos
M. Santos
AGA. Gil-Brusola
A. Gil-Brusola
PMP. Morales
P. Morales

1 December 2007 in Revista Iberoamericana de Micologia
Verified
Journal Article
Closed access
AGAna Gil-Brusola
Ana Gil-Brusola
JPJavier Pemán
Javier Pemán
MSMaría Santos
María Santos
MSMiguel Salavert
Miguel Salavert
JLJose Lacruz
Jose Lacruz
MGMiguel Gobernado
Miguel Gobernado

19 February 2014 in Pathology Research International
Verified
Journal Article
Open access
PDF file
MSM. Santos
M. Santos
AGA. Gil-Brusola
A. Gil-Brusola
AEA. Escandell
A. Escandell
MBM. Blanes
M. Blanes
MGM. Gobernado
M. Gobernado
Mycobacterium genavense is a relatively new species of nontuberculous mycobacterium reported to cause disseminated infections in patients with AIDS and later on in non-HIV immunosuppressed patients. We describe clinical and laboratory features and response to therapy in 7 patients, three of them with HIV infection and four non-HIV—three organ transplant recipients and one with hyper-IgE syndrome—in Valencia, Spain, in a ten years period. We then summarize the published cases of M. avium complex infection, with invasion of peripheral blood, liver, spleen, bone marrow, lymph nodes, and lungs. In clinical samples a large number of acid-fast bacilli were observed. M. genavense grew only from liquid media and after a prolonged incubation period. Its identification was accomplished through molecular methods. Patients were treated with prolonged combinations of antimicrobial agents. There was clinical favourable outcome in 4 patients.